help button home button
AJRCCM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Published ahead of print on January 18, 2005, doi:10.1164/rccm.200311-1508OC
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
200311-1508OCv1
171/8/868    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Barker, P. M.
Right arrow Articles by Rubin, B. K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Barker, P. M.
Right arrow Articles by Rubin, B. K.
American Journal of Respiratory and Critical Care Medicine Vol 171. pp. 868-871, (2005)
© 2005 American Thoracic Society
doi: 10.1164/rccm.200311-1508OC

Original Article

Effect of Macrolides on In Vivo Ion Transport across Cystic Fibrosis Nasal Epithelium

Pierre M. Barker, Daniel J. Gillie, Michael S. Schechter and Bruce K. Rubin

Department of Pediatrics, University of North Carolina at Chapel Hill, Chapel Hill; Department of Pediatrics, Wake Forest University School of Medicine, Winston-Salem, North Carolina; and Brown Medical School, Providence, Rhode Island

Correspondence and requests for reprints should be addressed to Pierre M. Barker, M.D., Department of Pediatrics, University of North Carolina at Chapel Hill, 200 Mason Farm Road, Chapel Hill, NC 27599-7220. E-mail: pbarker{at}med.unc.edu

Fourteen- and 15-member macrolide antibiotics are under investigation as potential therapeutic agents for cystic fibrosis (CF). The nonantibiotic mechanisms of action of these compounds in CF are not understood. We used nasal potential difference (NPD) measurements to test the effect of macrolides on airway epithelial ion (chloride, sodium) transport of CF mice and humans. We tested clarithromycin and azithromycin in mice, and clarithromycin in patients with CF. Baseline and post-treatment NPD was measured in two strains (C57Bl6 and BalbC) of CF transmembrane regulator "knockout" and littermate control mice, and in {Delta}F508/{Delta}F508 mice. In addition, NPD was measured in 18 human subjects with CF (17 {Delta}F-508/{Delta}F-508 and 1 {Delta}F-508/other) who were undergoing a 12-month, randomized, double-blind crossover study of the effects of clarithromycin on pulmonary outcome in CF. Neither clarithromycin nor azithromycin affected ion transport characteristics of normal or CF nasal epithelium in either mouse or humans. We conclude that the apparent beneficial effects of macrolides on pulmonary outcome in CF are not mediated by their modulation of ion transport.

Key Words: antibiotic • chloride • nasal potential difference • therapy




This article has been cited by other articles:


Home page
 Am. J. Respir. Cell Mol. Bio.Home page
L. Chen, C. A. Bosworth, T. Pico, J. F. Collawn, K. Varga, Z. Gao, J. P. Clancy, J. A. Fortenberry, J. R. Lancaster Jr., and S. Matalon
DETANO and Nitrated Lipids Increase Chloride Secretion across Lung Airway Cells
Am. J. Respir. Cell Mol. Biol., August 1, 2008; 39(2): 150 - 162.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Crit. Care Med.Home page
F. J. Accurso
Update in cystic fibrosis 2005.
Am. J. Respir. Crit. Care Med., May 1, 2006; 173(9): 944 - 947.
[Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Proc. Am. Thorac. Soc. Am. J. Respir. Cell Mol. Biol.
Copyright © 2005 American Thoracic Society 		  ATS State of the Art 2009